MIMETAS develops predictive human tissue & disease models using organ-on-a-chip technology. Her core-product, the OrganoPlate®, allows perfused 3D cell culture, membrane free co-culture & culture of tubules and vessels. MIMETAS works for nearly all major pharmaceutical companies worldwide on models for compound screening and toxicity testing.